64
Participants
Start Date
February 28, 2009
Primary Completion Date
February 28, 2011
Study Completion Date
February 29, 2012
Nexavar (Sorafenib) and irinotecan (Campto)
Sorafenib administrated continuously orally 400 mg twice daily (a daily total dose of 800 mg). Irinotecan 180 mg/m² will be administered IV for 90 minutes every 2 weeks. The first dose of sorafenib will be administered after the first perfusion of irinotecan 180 mg/m² at the first infusion
Centre Oscar Lambret, Lille
Hopital Saint Eloi, Montpellier
Centre Rene Gauducheau, Nantes
Centre Antoine Lacassagne, Nice
CHU Robert Debre, Reims
Collaborators (1)
Bayer
INDUSTRY
Institut du Cancer de Montpellier - Val d'Aurelle
OTHER